Navigation Links
Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
Date:9/26/2007

COLORADO SPRINGS, Colo., Sept. 26 /PRNewswire-FirstCall/ -- Spectranetics Corporation (Nasdaq: SPNC) today announced it has enrolled the first patient in the PATENT trial utilizing the Company's TURBO elite(TM) laser catheters in combination with the recently FDA cleared TURBO-Booster(TM).

The PATENT trial is a prospective registry of 100 patients at up to 10 sites in Germany. The trial will assess patency as measured by duplex ultrasound at various intervals up to 12 months following the procedure. It will also assess safety as measured by adverse events up to 12 months following the procedure. In the initial procedure performed at the Leipzig Heart Center, four focal lesions were treated successfully with the TURBO-Booster and TURBO elite 2.0mm catheter in a 20cm long stented superficial femoral artery.

"The initial result from this Spectranetics device looks very promising, as the new features allow for ablation of more tissue in larger vessels," said Andrej Schmidt, M.D., of the University of Leipzig-Heart Center. "Instent restenosis in a superficial femoral artery represents one of the most challenging procedures in our practice. The current standard of care, such as repeat balloon angioplasty, does not have good results as these lesions tend to reoccur. We are very excited with the start of this study in Germany, and we look forward to examining the mid- and long-term results of this new therapy."

John G. Schulte, Spectranetics' President and Chief Executive Officer, commented, "We are very pleased to have begun this trial at one of Europe's most prestigious medical centers. We believe that instent restenosis in the superficial femoral artery may represent 25% to 35% of all above-the-knee proce
'/>"/>

SOURCE Spectranetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/6tdwh8/medical_device ) ... Device Outsourcing - Global Strategic Business Report" ... analyzes the worldwide markets for Medical Device Outsourcing ... Class I, Class II, and Class III. The ... - Radiology, Orthopedic, Neurology, Cardiology, and Others. ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ) ... Rental and Leasing - Global Strategic Business Report" ... the worldwide markets for Medical Equipment Rental and Leasing ... for the US, Japan , ... Annual estimates and forecasts are provided for the ...
(Date:4/17/2015)... , April 17, 2015 ASSESS ... mutation   is a viable alternative to tumour biopsy   ... in all patients with advanced NSCLC   AstraZeneca ... of plasma circulating tumour DNA (ctDNA) testing for epidermal growth ... advanced non-small cell lung cancer (NSCLC) in clinical practice. [ ...
Breaking Medicine Technology:Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 2Medical Device Outsourcing (Radiology, Orthopedic, Neurology, Cardiology, and Others) Market 2015 - Global Strategic Business Report 3Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 2"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 3"Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC 4
... , WAYNE, Pa., Nov. 20 Escalon Medical Corp. (Nasdaq ... ended September 30, 2009. , For the first ... 2.7%, to $8,435,000 during the three-month period ended September 30, ... The Company reported the decreased net revenue of $8,434,000 ...
... , LOUISVILLE, Ky., Nov. ... today announced a new initiative in the war on methamphetamine. ... electronic tracking program that enforces purchase limitations on over-the-counter (OTC) ... The technology for NPLEx is based on a system ...
Cached Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3
(Date:4/18/2015)... April 18, 2015 Carinsurancequotesinfo.com has released ... can cover physical injuries caused by a car ... financial coverage for a vehicle. A policy can pay ... an accident. Drivers should always carry appropriate coverage when ... policy can be bought with several important riders that ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 "I recognized ... stretchers in healthcare facilities," said an inventor from Cincinnati, ... storage system." , He developed the Slyde Door to ... used in healthcare facilities. It provides convenient storage space ... are more stretchers available for patients. , This ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining ... , Clients can review important auto insurance quotes ... provides important advantages for clients who need affordable financial ... not have coverage for their vehicles can purchase a ... hour. Many agencies offer important discounts and drivers can ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Patients who ... of developing mesothelioma later in life, but the disease ... mesothelioma that is unrelated to radiation. Surviving Mesothelioma has ... its website. Click here to read it now. ... compared the cases of 45 patients who had both ...
(Date:4/18/2015)... More than 2000 styles of newly ... the #1 online store carrying celebrity inspired special occasion ... got their perfect dresses for their prom. For those ... dresses at TheCelebrityDresses.com would be an ideal choice. ... prom dresses inspired by the most loved styles seen ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2
... 2, 2008 Rochester,Medical Corporation (Nasdaq: ROCM ... now allows intermittent catheter users to benefit from,not ... 2008, the four regional Durable Medical Equipment,(DME) Medicare ... a new reimbursement policy covering the use of,Intermittent ...
... is being released by the National Association of Boards ... and convenient when,patients use legitimate online pharmacies, but it ... recipients of counterfeit drugs from,dishonest Web sites. The vast ... "buyer beware" situations as it is often difficult,for them ...
... ... Heroes, FORT WORTH, Texas, ... flight attendants who,have administered emergency medical attention by using onboard,defibrillators. Flight attendants ... to celebrate the lives saved and heroic,measures taken during medical emergencies inflight ...
... cancer incidence not clear yet, expert says , , WEDNESDAY, ... on chromosome 15 that has three nicotine receptor genes that ... finding offers yet more evidence that lung cancer is tied ... variants represent a direct risk for lung cancer and ...
... Mo., April 2, 2008 As the use ... threatened,with greater liability for loss associated with unauthorized ... Stuckey & Company gives critical,professional liability options that ... Their technology insurance program can give,both 1st and ...
... A substantial,proportion of the nation,s public school ... school students, some possibly going beyond,sanctions set by ... led by the,Pacific Institute for Research and Evaluation ... sports and extracurricular activities., The study, funded ...
Cached Medicine News:Health News:Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters 2Health News:Indiana Adopts Legislation to Combat Illegitimate Online Pharmacies, Protect Residents From Counterfeit Drugs 2Health News:Indiana Adopts Legislation to Combat Illegitimate Online Pharmacies, Protect Residents From Counterfeit Drugs 3Health News:American Airlines Honors Flight Attendants at Golden Heart Awards Ceremony 2Health News:Gene Variants Linked to Lung Cancer Identified 2Health News:Gene Variants Linked to Lung Cancer Identified 3Health News:Gene Variants Linked to Lung Cancer Identified 4Health News:Digital Technology Exposes Business to Greater Liability 2Health News:Recent Study Finds That a Substantial Number of Public School Districts Conduct Random Drug Testing with High School Students 2
This is an antigen-capture assay intended for the detection of histidine-rich protein ll (PfHRP-ll), which is released from Malaria-infected red blood cells....
Core Malaria Pf is a rapid self performing, qualitative, two site sandwich immunoassay for the determination of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples...
Ultraview 1700 Central Monitor...
The Hypervisor VI is a solution for telemetry, LAN and wireless LAN networking. It includes bi-directional communication with Mindray bedside patient monitors and can store waveforms and numeric info...
Medicine Products: